Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Hormone implant for prostate and breast cancer and endometriosis. | Depot injection that shuts down testosterone or oestrogen production. |
| Body system | Cancer | Cancer |
| Drug class | GnRH analogues | GnRH analogues |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Advanced prostate cancer, Breast cancer in premenopausal women, Endometriosis, Fibroids before surgery | Advanced prostate cancer, Breast cancer in premenopausal women, Endometriosis and fibroids, Early (central) puberty |
| How it works | Switches off sex hormone production. | Switches off sex hormone production. |
| Starts working | Depends on the cancer and regimen | Depends on the cancer and regimen |
| Half-life | About 4 hours (effect lasts the implant interval) | About 3 hours (effect lasts the depot interval) |
| Typical adult dose | Dosed by your cancer team according to the treatment protocol. | Dosed by your cancer team according to the treatment protocol. |
| Forms | Subcutaneous implant | Depot injection |
| Common side effects | Hot flushes, Reduced sex drive, Headache, Mood changes, Injection site bruising | Hot flushes, Reduced sex drive, Erectile dysfunction, Injection site pain, Mood changes |
| Serious side effects | Tumour flare at the start, Bone thinning, Ovarian cyst (rare) | Tumour flare at the start, Bone thinning with long use, Heart and diabetes risk (observed) |
| Don't take if | Pregnancy; Undiagnosed vaginal bleeding | Pregnancy; Undiagnosed vaginal bleeding |
| Alcohol | Usually no problem in moderation. No specific interaction. | Usually no problem in moderation. No specific interaction. |
| Pregnancy | Usually avoidedAvoid. | Usually avoidedAvoid. |
| Breastfeeding | Usually avoidedAvoid. | Usually avoidedAvoid. |
| In use since | — | — |
| Brand names | United States: ZoladexUnited Kingdom: ZoladexIndia: Zoladex, Gosecare | United States: Lupron Depot, EligardUnited Kingdom: Prostap, Lutrate, EligardIndia: Lupride, Lupron |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H |
| ATC code | L02AE03 | L02AE02 |
Taken together
- ModerateGoserelin + Leuprorelin: Additive QT prolongation
Both medicines can lengthen the QT interval. The risk is higher with heart disease, low potassium or magnesium, older age and female sex.